VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.68%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$223M
AUM Growth
-$41.4M
(-16%)
Cap. Flow
-$33.4M
Cap. Flow
% of AUM
-14.95%
Top 10 Holdings %
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47
Top Buys
| 1 |
The Mosaic Company
MOS
|
$2.75M |
| 2 |
STR
Sitio Royalties
STR
|
$2.32M |
| 3 |
Copel
ELP
|
$2.31M |
| 4 |
Vale
VALE
|
$2.26M |
| 5 |
Nutrien
NTR
|
$2.24M |
Top Sells
| 1 |
Boise Cascade
BCC
|
$2.62M |
| 2 |
Extra Space Storage
EXR
|
$2.49M |
| 3 |
Canadian Natural Resources
CNQ
|
$2.46M |
| 4 |
Imperial Oil
IMO
|
$2.45M |
| 5 |
Avient
AVNT
|
$2.42M |
Sector Composition
| 1 | Materials | 20.16% |
| 2 | Real Estate | 20.02% |
| 3 | Healthcare | 16.51% |
| 4 | Energy | 10.55% |
| 5 | Utilities | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
C4 Therapeutics
CCCC
$200M
| $128K | 0.06% |
5,275
-314
| -6% | -$7.62K |
|
|
VXRT
252
DELISTED
Vaxart
VXRT
| $128K | 0.06% |
25,383
-1,500
| -6% | -$7.56K |
|
|
AFMD
253
DELISTED
Affimed
AFMD
| $126K | 0.06% |
2,887
-172
| -6% | -$7.51K |
|
254
Dynavax Technologies
DVAX
$1.18B
| $126K | 0.06% |
11,592
-685
| -6% | -$7.45K |
|
|
CNTA
255
Centessa Pharmaceuticals
CNTA
$2.13B
| $125K | 0.06% |
13,969
-829
| -6% | -$7.42K |
|
256
Arcus Biosciences
RCUS
$1.26B
| $125K | 0.06% |
3,954
-225
| -5% | -$7.11K |
|
257
AC Immune
ACIU
$224M
| $124K | 0.06% |
31,014
-1,838
| -6% | -$7.35K |
|
258
Protagonist Therapeutics
PTGX
$3.7B
| $124K | 0.06% |
5,216
-305
| -6% | -$7.25K |
|
|
AGEN
259
Agenus
AGEN
$134M
| $123K | 0.06% |
2,540
-151
| -6% | -$7.31K |
|
260
Kymera Therapeutics
KYMR
$3.11B
| $123K | 0.06% |
2,898
-173
| -6% | -$7.34K |
|
261
Cassava Sciences
SAVA
$104M
| $123K | 0.06% |
3,299
-200
| -6% | -$7.46K |
|
262
Xencor
XNCR
$616M
| $123K | 0.06% |
4,592
-277
| -6% | -$7.42K |
|
263
AnaptysBio
ANAB
$615M
| $122K | 0.05% |
4,949
-286
| -5% | -$7.05K |
|
264
Arcturus Therapeutics
ARCT
$488M
| $122K | 0.05% |
4,532
-271
| -6% | -$7.3K |
|
265
Compugen
CGEN
$134M
| $122K | 0.05% |
37,909
-2,252
| -6% | -$7.25K |
|
266
GH Research
GHRS
$873M
| $122K | 0.05% |
6,687
-399
| -6% | -$7.28K |
|
267
Sangamo Therapeutics
SGMO
$166M
| $122K | 0.05% |
20,983
-1,244
| -6% | -$7.23K |
|
|
DICE
268
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $121K | 0.05% |
6,316
-367
| -5% | -$7.03K |
|
269
Fate Therapeutics
FATE
$113M
| $120K | 0.05% |
3,091
-183
| -6% | -$7.1K |
|
|
CMRX
270
DELISTED
Chimerix, Inc.
CMRX
| $119K | 0.05% |
25,976
-1,538
| -6% | -$7.05K |
|
|
IMGN
271
DELISTED
Immunogen Inc
IMGN
| $118K | 0.05% |
24,846
-1,477
| -6% | -$7.02K |
|
272
Immunovant
IMVT
$2.96B
| $117K | 0.05% |
21,162
-1,273
| -6% | -$7.04K |
|
273
Phathom Pharmaceuticals
PHAT
$886M
| $117K | 0.05% |
8,575
-505
| -6% | -$6.89K |
|
274
4D Molecular Therapeutics
FDMT
$333M
| $116K | 0.05% |
7,683
-457
| -6% | -$6.9K |
|
275
Legend Biotech
LEGN
$6.63B
| $116K | 0.05% |
3,195
-189
| -6% | -$6.86K |
|